Fosun Pharma reduces its stake in Gland Pharma, selling 4.5% through block deals on BSE, attracting several major investors ...

Novartis India is set to enhance its growth strategy with therapy-aligned acquisitions while expanding its reach in Tier 2 ...

Novartis' experimental heart drug pelacarsen missed key goals in a late-stage trial, leading to a significant drop in shares ...

India's drug regulator has flagged a batch of the widely used rabies vaccine Abhayrab as substandard, prompting ...

Lupin Ltd has received USFDA approval for Modafinil tablets (100 mg and 200 mg) used to treat excessive sleepiness associated ...

Cipla has entered a licensing agreement to market Qil2107, a biosimilar of Keytruda in the US. The partnership aims to ...

Recent studies suggest that psilocybin, a psychedelic drug, may effectively prevent nerve damage caused by chemotherapy.

Ionis Pharmaceuticals' injectable drug, Zanvastro, has received FDA approval, becoming the first treatment for Alexander ...

RPG Life Sciences expands its portfolio by acquiring Raghava Life Science's API and Intermediates business for ₹135 crore, ...

HUTCHMED has announced a $110 million upfront licensing agreement with GlaxoSmithKline for HMPL-A830, an experimental drug ...

The Indian pharmaceutical industry opposes a new regulatory proposal that holds drug manufacturers accountable for ...